The objective of this study was to determine a risk factor for predicting bacterial infection in patients, who survived out-of-hospital cardiac arrest (OHCA), during targeted temperature management (TTM). This prospective registry-based retrospective observational study was conducted from November 2010 to October 2017. We measured several biomarkers such as whole blood cell counts, and levels of C-reactive protein and procalcitonin daily during TTM. The primary outcome was bacterial growth in initial blood or sputum cultures. A total of 116 patients were analyzed in this study. The bacterial growth rate was 32.8% and the procalcitonin levels measured at 24 h from cardiac arrest was significantly higher in the culture-positive group than the culture-negative group (10.6 vs. 2.5 ng/mL, p = 0.017). Area under the receiver operating characteristic curve for procalcitonin obtained after 24 h was 0.727 and the cutoff value was 6.5 ng/mL (odds ratio 9.58 [95% confidential interval, CI 2.21–41.55], p = 0.003). Sensitivity was 71.4% [95% CI 41.9–91.6] and specificity was 79.3% [95% CI 60.3–92.0]. Procalcitonin measured at 24 h from cardiac arrest was associated with bacterial infection in OHCA patients undergoing TTM. Further prospective interventional studies are needed to validate these results.
Get full access to this article
View all access options for this article.
References
1.
BeckerKL, SniderR, NylenES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med, 2008; 36:941–952.
2.
BernardSA, GrayTW, BuistMD, JonesBM, SilvesterW, GutteridgeG, et al.Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med, 2002; 346:557–563.
CallawayCW, DonninoMW, FinkEL, GeocadinRG, GolanE, KernKB, et al.Part 8: post-cardiac arrest care: 2015 American heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation, 2015; 132:S465–S482.
5.
Christ-CrainM, StolzD, BingisserR, MullerC, MiedingerD, HuberPR, et al.Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med, 2006; 174:84–93.
6.
CobaV, JaehneAK, SuarezA, DagherGA, BrownSC, YangJJ, et al.The incidence and significance of bacteremia in out of hospital cardiac arrest. Resuscitation, 2014; 85:196–202.
7.
Dell'nnaAM, Bini ViottiJ, BeumierM, Orbegozo-CortesD, DonadelloK, ScollettaS, et al.C-reactive protein levels after cardiac arrest in patients treated with therapeutic hypothermia. Resuscitation, 2014; 85:932–938.
8.
GeurtsM, MacleodMR, KollmarR, KremerPH, van der WorpHB. Therapeutic hypothermia and the risk of infection: a systematic review and meta-analysis. Crit Care Med, 2014; 42:231–242.
9.
GoleaA, RusuA, DumulescC, BalaC. Investigation of biomarker variations post-return of spontaneous circulation following an out-of-hospital cardiac arrest. Rev Romana Med Lab, 2017; 25:245–254.
10.
GulSS, HuesgenKW, WangKK, MarkK, TyndallJA. Prognostic utility of neuroinjury biomarkers in post out-of-hospital cardiac arrest (OHCA) patient management. Med Hypotheses, 2017; 105:34–47.
11.
Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med, 2002; 346:549–556.
12.
KroupaJ, KnotJ, UlmanJ, BednarF, DohnalovaA, MotovskaZ. Clinical and laboratory predictors of infectious complications in patients after out-of-hospital cardiac arrest. J Crit Care, 2017; 42:85–91.
13.
LeeBK, ParkKN, KangGH, KimKH, KimG, KimWY, et al.Outcome and current status of therapeutic hypothermia after out-of-hospital cardiac arrest in Korea using data from the Korea Hypothermia Network registry. Clin Exp Emerg Med, 2014; 1:19–27.
14.
LeeH. Procalcitonin as a biomarker of infectious diseases. Korean J Intern Med, 2013; 28:285–291.
15.
MeisnerM. Update on procalcitonin measurements. Ann Lab Med, 2014; 34:263–273.
16.
MongardonN, PerbetS, LemialeV, DumasF, PoupetH, CharpentierJ, et al.Infectious complications in out-of-hospital cardiac arrest patients in the therapeutic hypothermia era. Crit Care Med, 2011; 39:1359–1364.
17.
NielsenN, WetterslevJ, Al-SubaieN, AnderssonB, Bro-JeppesenJ, BishopG, et al.Target temperature management after out-of-hospital cardiac arrest—a randomized, parallel-group, assessor-blinded clinical trial—rationale and design. Am Heart J, 2012; 163:541–548.
18.
NielsenN, WetterslevJ, CronbergT, ErlingeD, GascheY, HassagerC, et al.Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med, 2013; 369:2197–2206.
19.
NolanJP, MorleyPT, Vanden HoekTL, HickeyRW, KloeckWG, BilliJ, et al.Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation, 2003; 108:118–121.
20.
NoyesAM, LundbyeJB. Managing the complications of mild therapeutic hypothermia in the cardiac arrest patient. J Intensive Care Med, 2015; 30:259–269.
21.
OliveiraCF, BotoniFA, OliveiraCR, SilvaCB, PereiraHA, SerufoJC, et al.Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med, 2013; 41:2336–2343.
PovoaP, SalluhJI. Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review. Ann Intensive Care, 2012; 2:32.
24.
RibaricSF, TurelM, KnafeljR, GorjupV, StanicR, GradisekP, et al.Prophylactic versus clinically-driven antibiotics in comatose survivors of out-of-hospital cardiac arrest-a randomized pilot study. Resuscitation, 2017; 111:103–109.
25.
RyooSM, KimWY, SohnCH, SeoDW, KohJW, OhBJ, et al.Prognostic value of timing of antibiotic administration in patients with septic shock treated with early quantitative resuscitation. Am J Med Sci, 2015; 349:328–333.
26.
SchuetzP, AffolterB, HunzikerS, WinterhalderC, FischerM, BalestraGM, et al.Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: a retrospective cohort study. Eur J Clin Invest, 2010; 40:376–381.
27.
SprostonNR, AshworthJJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol, 2018; 9:754.
TadieJM, HemingN, ServeE, WeissN, DayN, ImbertA, et al.Drowning associated pneumonia: a descriptive cohort. Resuscitation, 2012; 83:399–401.
30.
XiaoGG, GuoQ, ShuM, XieXP, DengJJ, ZhuY, et al.Safety profile and outcome of mild therapeutic hypothermia in patients following cardiac arrest: systematic review and meta-analysis. Emerg Med J, 2013; 30:91–100.
